Search by Drug Name or NDC
NDC 60631-0080-30 Edarbi 80 mg/1 Details
Edarbi 80 mg/1
Edarbi is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Azurity Pharmaceuticals, Inc. (formerly Arbor Pharmaceuticals). The primary component is AZILSARTAN KAMEDOXOMIL.
MedlinePlus Drug Summary
Azilsartan is used alone or in combination with other medications to treat high blood pressure. Azilsartan is in a class of medications called angiotensin II receptor antagonists. It works by blocking the action of certain natural substances that tighten the blood vessels, allowing the blood to flow more smoothly and the heart to pump more efficiently. High blood pressure is a common condition, and when not treated it can cause damage to the brain, heart, blood vessels, kidneys, and other parts of the body. Damage to these organs may cause heart disease, a heart attack, heart failure, stroke, kidney failure, loss of vision, and other problems. In addition to taking medication, making lifestyle changes will also help to control your blood pressure. These changes include eating a diet that is low in fat and salt, maintaining a healthy weight, exercising at least 30 minutes most days, not smoking, and using alcohol in moderation.
Related Packages: 60631-0080-30Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Azilsartan
Product Information
| NDC | 60631-0080 |
|---|---|
| Product ID | 60631-080_af23aeaf-1efa-46f0-aed0-f9d5221e67fd |
| Associated GPIs | 36150010200330 |
| GCN Sequence Number | 067115 |
| GCN Sequence Number Description | azilsartan medoxomil TABLET 80 MG ORAL |
| HIC3 | A4F |
| HIC3 Description | ANTIHYPERTENSIVES, ANGIOTENSIN RECEPTOR ANTAGONIST |
| GCN | 29597 |
| HICL Sequence Number | 037444 |
| HICL Sequence Number Description | AZILSARTAN MEDOXOMIL |
| Brand/Generic | Brand |
| Proprietary Name | Edarbi |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Azilsartan kamedoxomil |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | TABLET |
| Route | ORAL |
| Active Ingredient Strength | 80 |
| Active Ingredient Units | mg/1 |
| Substance Name | AZILSARTAN KAMEDOXOMIL |
| Labeler Name | Azurity Pharmaceuticals, Inc. (formerly Arbor Pharmaceuticals) |
| Pharmaceutical Class | Angiotensin 2 Receptor Blocker [EPC], Angiotensin 2 Type 1 Receptor Antagonists [MoA], Decreased Blood Pressure [PE] |
| DEA Schedule | n/a |
| Marketing Category | NDA |
| Application Number | NDA200796 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 60631-0080-30 (60631008030)
| NDC Package Code | 60631-080-30 |
|---|---|
| Billing NDC | 60631008030 |
| Package | 30 TABLET in 1 BOTTLE (60631-080-30) |
| Marketing Start Date | 2013-02-01 |
| NDC Exclude Flag | N |
| Pricing Information | |
| Price Per Unit | 8.26674 |
| Pricing Unit | EA |
| Effective Date | 2024-01-01 |
| NDC Description | EDARBI 80 MG TABLET |
| Pharmacy Type Indicator | C/I |
| OTC | N |
| Explanation Code | 4 |
| Classification for Rate Setting | B |
| As of Date | 2024-02-21 |